Yazar "Kaen, Diego" seçeneğine göre listele
Listeleniyor 1 - 2 / 2
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe AMEERA-3, a phase 2 trial of SAR439859 vs endocrine monotherapy in pre- and post-menopausal, estrogen receptor-positive (ER plus )/human epidermal growth factor receptor 2-negative (her2-), locally advanced or metastatic breast cancer (BC) with prior exposure to hormonal therapies(Amer Assoc Cancer Research, 2021) Tolaney, Sara; Cicin, Irfan; Betancourt, Rafael; Chan, Arlene; Kaen, Diego; Kaufman, Peter; Delaloge, Suzette[Abstract Not Available]Öğe Phase II trial of SAR439859 vs endocrine monotherapy in pre- and post-menopausal, estrogen receptor-positive (ER plus )/human epidermal growth factor receptor 2-negative (HER2-), locally advanced or metastatic breast cancer (BC) with prior exposure to hormonal therapies.(Lippincott Williams & Wilkins, 2020) Tolaney, Sara M.; Cicin, Irfan; Betancourt, Rafael; Chan, Arlene; Kaen, Diego; Kaufman, Peter A.; Delaloge, Suzette[Abstract Not Available]
